The importance of negative predictive value (NPV) of vulnerable elderly survey (VES 13) as a pre-screening test in older patients with cancer

Castagneto, B.; Di Pietrantonj, C.; Stevani, I.; Anfossi, A.; Arzese, M.; Giorcelli, L.; Giaretto, L.
December 2013
Medical Oncology;Dec2013, Vol. 30 Issue 4, p1
Academic Journal
No abstract available.


Related Articles

  • How to select elderly colorectal cancer patients for surgery: a pilot study in an Italian academic medical center. Ugolini, Giampaolo; Pasini, Francesco; Ghignone, Federico; Zattoni, Davide; Reggiani, Maria Letizia Bacchi; Parlanti, Daniele; Montroni, Isacco // Cancer Biology & Medicine;Dec2015, Vol. 12 Issue 4, p302 

    Objective: Cancer is one of the most common diagnoses in elderly patients. Of all types of abdominal cancer, colorectal cancer (CRC) is undoubtedly the most frequent. Median age at diagnosis is approximately 70 years old worldwide. Due to the multiple comorbidities affecting elderly people,...

  • Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study. Soubeyran, Pierre; Bellera, Carine; Goyard, Jean; Heitz, Damien; Curé, Hervé; Rousselot, Hubert; Albrand, Gilles; Servent, Véronique; Jean, Olivier Saint; van Praagh, Isabelle; Kurtz, Jean-Emmanuel; Périn, Stéphane; Verhaeghe, Jean-Luc; Terret, Catherine; Desauw, Christophe; Girre, Véronique; Mertens, Cécile; Mathoulin-Pélissier, Simone; Rainfray, Muriel // PLoS ONE;Dec2014, Vol. 9 Issue 12, p1 

    Background: Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify the best screening tool to identify...

  • Four screening instruments for frailty in older patients with and without cancer: a diagnostic study. Smets, Ineke H. G. J.; Kempen, Gertrudis I. J. M.; Janssen-Heijnen, Maryska L. G.; Deckx, Laura; Buntinx, Frank J. V. M.; van den Akker, Marjan // BMC Geriatrics;2014, Vol. 14 Issue 1, p1 

    Background Frailty in older patients might influence treatment decisions. Frailty can be determined using a Comprehensive Geriatric Assessment (CGA), but this is time-consuming and expensive. Therefore we assessed the diagnostic value of four shorter screening instruments. Methods We tested the...

  • Last Word. Wierks, Carl H.; Labropoulos, Nicos // Perspectives in Vascular Surgery & Endovascular Therapy;Apr2004, Vol. 16 Issue 2, p101 

    The article discusses the importance of defining positive predictive values (PPV) and negative predictive values (NPV) in diagnostic studies. It is of significance to recognize in what setting the diagnostic method is used. the sensitivity and specificity may depend on the spectrum of disease in...

  • Predicting fatigue in older breast cancer patients receiving radiotherapy. Denkinger, Michael Dieter; Hasch, Melanie; Gerstmayer, Anna; Kreienberg, Rolf; Nikolaus, Thorsten; Hancke, Katharina // Zeitschrift für Gerontologie und Geriatrie;Feb2015, Vol. 48 Issue 2, p128 

    Objectives: Because of substantial toxicities in older adults, chemotherapy is often omitted while the frequency of radiotherapy changes only minimally. In this study, we addressed the value of different assessments for predicting fatigue after radiotherapy in older breast cancer patients....

  • Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool? Biganzoli, L.; Boni, L.; Becheri, D.; Zafarana, E.; Biagioni, C.; Cappadona, S.; Bianchini, E.; Oakman, C.; Magnolfi, S. U.; Di Leo, A.; Mottino, G. // Annals of Oncology;Feb2013, Vol. 24 Issue 2, p494 

    Background A geriatric screening tool would be valuable to identify elderly cancer patients who might benefit from a comprehensive geriatric assessment (CGA). This study evaluated the accuracy of the cardiovascular health study (CHS) instrument in predicting abnormality in CGA. The vulnerable...

  • Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations† Decoster, L.; Van Puyvelde, K.; Mohile, S.; Wedding, U.; Basso, U.; Colloca, G.; Rostoft, S.; Overcash, J.; Wildiers, H.; Steer, C.; Kimmick, G.; Kanesvaran, R.; Luciani, A.; Terret, C.; Hurria, A.; Kenis, C.; Audisio, R.; Extermann, M. // Annals of Oncology;Feb2015, Vol. 26 Issue 2, p288 

    Background: Screening tools are proposed to identify those older cancer patients in need of geriatric assessment (GA) and multidisciplinary approach. We aimed to update the International Society of Geriatric Oncology (SIOG) 2005 recommendations on the use of screening tools. Materials and...

  • Preoperative risk estimation for onco-geriatric patients (PREOP) -- preoperative assessment of elderly surgical patients. Farinella, Eriberto; La Mura, Francesco; Cirocchi, Roberto; Delmonaco, Pamela; Migliaccio, Carla; Giustozzi, Giammario; Sciannameo, Francesco; Audisio, Riccardo A. // BMC Geriatrics;2009 Supplement 1, Vol. 9, Special section p1 

    Background Most cancer patients undergoing surgery are aged ≥ 70, with 1/3 considered frail and at poor surgical risk. Preoperative assessment of oncogeriatric patients may expand survival and improve quality of life. Preoperative Assessment of Cancer in the Elderly (PACE) was useful in...

  • A method to predict breast cancer stage using Medicare claims. Smith, Grace L.; Shih, Ya-Chen T.; Giordano, Sharon H.; Smith, Benjamin D.; Buchholz, Thomas A. // Epidemiologic Perspectives & Innovations;2010, Vol. 7, p1 

    Background: In epidemiologic studies, cancer stage is an important predictor of outcomes. However, cancer stage is typically unavailable in medical insurance claims datasets, thus limiting the usefulness of such data for epidemiologic studies. Therefore, we sought to develop an algorithm to...

  • A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer. Bauman, Julie E.; Eaton, Keith D.; Wallace, Sarah G.; Carr, Laurie L.; Lee, Sang-Joon; Jones, Dennie V.; Arias-Pulido, Hugo; Cerilli, Lisa A.; Martins, Renato G. // BMC Cancer;2012, Vol. 12 Issue 1, p449 

    Background: In non-small cell lung cancer (NSCLC), interstitial hypertension is a barrier to chemotherapy delivery, and is mediated by platelet derived growth factor receptor (PDGFR). Antagonizing PDGFR with imatinib may improve intra-tumoral delivery of paclitaxel, increasing response rate...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics